Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fixed vs Variable Dosing of 4FPCC for Warfarin Reversal
NCT03064035Phase 4Completed
- Sponsor
- HealthPartners Institute
- Start
- Apr 2017
- Primary completion
- Apr 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of coagulation factor X human in coagulopathy, hemorrhage, sponsored by HealthPartners Institute. Started Apr 2017; status: completed.
02
Drugs
coagulation factor X human
03
Conditions
coagulopathyhemorrhage
Beyond the preview
Go deeper on NCT03064035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03064035.